These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 23098733)

  • 1. Defeating inhibition of regeneration by scar and myelin components.
    Fawcett JW; Schwab ME; Montani L; Brazda N; Müller HW
    Handb Clin Neurol; 2012; 109():503-22. PubMed ID: 23098733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelin-, reactive glia-, and scar-derived CNS axon growth inhibitors: expression, receptor signaling, and correlation with axon regeneration.
    Sandvig A; Berry M; Barrett LB; Butt A; Logan A
    Glia; 2004 May; 46(3):225-51. PubMed ID: 15048847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter inhibitors in CNS axon regeneration failure.
    Xie F; Zheng B
    Exp Neurol; 2008 Feb; 209(2):302-12. PubMed ID: 17706966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myelin-associated inhibitors in axonal growth after CNS injury.
    Geoffroy CG; Zheng B
    Curr Opin Neurobiol; 2014 Aug; 27():31-8. PubMed ID: 24608164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined genetic attenuation of myelin and semaphorin-mediated growth inhibition is insufficient to promote serotonergic axon regeneration.
    Lee JK; Chow R; Xie F; Chow SY; Tolentino KE; Zheng B
    J Neurosci; 2010 Aug; 30(32):10899-904. PubMed ID: 20702718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myelin Associated Inhibitory Proteins as a Therapeutic Target for Healing of CNS Injury.
    Mukherjee N; Ghosh S
    ACS Chem Neurosci; 2020 Jun; 11(12):1699-1700. PubMed ID: 32484646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nogo on the go.
    McKerracher L; Winton MJ
    Neuron; 2002 Oct; 36(3):345-8. PubMed ID: 12408839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Nogo receptor, its ligands and axonal regeneration in the spinal cord; a review.
    Hunt D; Coffin RS; Anderson PN
    J Neurocytol; 2002 Feb; 31(2):93-120. PubMed ID: 12815233
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NEP1‑40 promotes myelin regeneration via upregulation of GAP‑43 and MAP‑2 expression after focal cerebral ischemia in rats.
    Zhao H; Liu ZD; Zhang YB; Gao XY; Wang C; Liu Y; Wang XF
    Mol Med Rep; 2021 Dec; 24(6):. PubMed ID: 34643252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased migration of olfactory ensheathing cells secreting the Nogo receptor ectodomain over inhibitory substrates and lesioned spinal cord.
    Reginensi D; Carulla P; Nocentini S; Seira O; Serra-Picamal X; Torres-Espín A; Matamoros-Angles A; Gavín R; Moreno-Flores MT; Wandosell F; Samitier J; Trepat X; Navarro X; del Río JA
    Cell Mol Life Sci; 2015 Jul; 72(14):2719-37. PubMed ID: 25708702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanisms of CNS myelin inhibition: evidence for distinct and neuronal cell type specific receptor systems.
    Giger RJ; Venkatesh K; Chivatakarn O; Raiker SJ; Robak L; Hofer T; Lee H; Rader C
    Restor Neurol Neurosci; 2008; 26(2-3):97-115. PubMed ID: 18820405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Nogo: a key strategy to increase regeneration, plasticity and functional recovery of the lesioned central nervous system.
    Buchli AD; Schwab ME
    Ann Med; 2005; 37(8):556-67. PubMed ID: 16338758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular approaches to spinal cord repair.
    David S; Lacroix S
    Annu Rev Neurosci; 2003; 26():411-40. PubMed ID: 12626698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization with myelin or recombinant Nogo-66/MAG in alum promotes axon regeneration and sprouting after corticospinal tract lesions in the spinal cord.
    Sicotte M; Tsatas O; Jeong SY; Cai CQ; He Z; David S
    Mol Cell Neurosci; 2003 Jun; 23(2):251-63. PubMed ID: 12812757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inhibitory proteins against axon regeneration in the central nervous system].
    Hu JG; Lu PH; Xu XM
    Sheng Li Ke Xue Jin Zhan; 2004 Oct; 35(4):311-4. PubMed ID: 15727207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptors for myelin inhibitors: Structures and therapeutic opportunities.
    Cao Z; Gao Y; Deng K; Williams G; Doherty P; Walsh FS
    Mol Cell Neurosci; 2010 Jan; 43(1):1-14. PubMed ID: 19619659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming inhibitors in myelin to promote axonal regeneration.
    Domeniconi M; Filbin MT
    J Neurol Sci; 2005 Jun; 233(1-2):43-7. PubMed ID: 15949495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury.
    Kim JE; Liu BP; Park JH; Strittmatter SM
    Neuron; 2004 Oct; 44(3):439-51. PubMed ID: 15504325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nerve regeneration: regrowth stumped by shared receptor.
    Watkins TA; Barres BA
    Curr Biol; 2002 Oct; 12(19):R654-6. PubMed ID: 12361584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localisation and expression of a myelin associated neurite inhibitor, Nogo-A and its receptor Nogo-receptor by mammalian CNS cells.
    Nyatia E; Lang DM
    Res Vet Sci; 2007 Dec; 83(3):287-301. PubMed ID: 17428512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.